Hottub News

FDA Grants Priority Review to Fenebrutinib for Relapsing and Progressive MS

3 reports from 3 outlets in 1 language · first reported · updated · JSON

HealthUnited States Food and Drug AdministrationfenebrutinibMato Grosso do SulGenentech

Reports

  1. FDA Grants Priority Review to Fenebrutinib for Relapsing and Progressive MSPublished by neurologyadvisor.com, empr.com ·
  2. Genentech: FDA Grants Priority Review To Fenebrutinib NDA For Relapsing And Primary Progressive MSrttnews.com · en ·

More in Health

  1. Former Eljamel patient’s ‘shock’ at health board’s approach to inquiry131 outlets
  2. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola93 outlets
  3. More than 4000 Ebola deaths in Democratic Republic of Congo59 outlets
  4. On ventilator and unconscious, what's next for Christa Pike after surviving lethal injection61 outlets
  5. Here's why experts say now is an ideal time to protect yourself from flu43 outlets
  6. Life expectancy almost back to pre-Covid levels, says WHO36 outlets